Drug reference
avibactam
β-Lactamase Inhibitor · β-Lactamase Inhibitor (Co-formulated with β-lactam antibiotics)
β-Lactamase Inhibitorβ-Lactamase Inhibitor (Co-formulated with β-lactam antibiotics)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Avibactam is a novel, structurally dissimilar non–β-lactam β-lactamase inhibitor with a broader spectrum of inhibition. It provides clinically useful inhibition against narrow- and extended-spectrum β-lactamase (ESBL)-type, chromosomal AmpC, and KPC-type β-lactamases (but not metallo-β-lactamases).
Drug interactions
1 additional unreviewed or low-confidence interaction hidden because their provenance or source detail is insufficient.
Related guidelines
Other β-Lactamase Inhibitor drugs
Ask House about avibactam
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Goodman & Gilman 14e·Updated: 2026-05-10